Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.

PanCAN has invested tens of millions of dollars in research grants to advance science and medicine and improve outcomes for patients. Learn more (https://www.pancan.org/research/) .

Latest from Pancreatic Cancer Action Network

Pancreatic Cancer Action Network Partners With Fibrogen To Bring New Experimental Treatment Arm To Adaptive Clinical Trial, Precision Promise

June 18, 2021

Article

Addition marks first experimental therapy offered as either first- or second-line option for pancreatic cancer patients enrolled in novel trial platform.

Siegfried Fischbacher of Siegfried and Roy Fame Dies From Pancreatic Cancer

January 14, 2021

Article

The other half of the Siegfried and Roy duo famous for their Vegas act died on Thursday from terminal pancreatic cancer.

Adaptive Clinical Trial Design Aims to Accelerate Research and Approvals in Pancreatic Cancer

December 02, 2020

Video

The research process for pancreatic cancer is long and difficult, but a new method of clinical trials is looking to adapt to a growing field and find ways to speed up research without losing efficiency.

PANCREATIC CANCER ACTION NETWORK ANNOUNCES GROUNDBREAKING CLINICAL TRIAL PLATFORM TRANSFORMING DEVELOPMENT OF TREATMENT OPTIONS FOR WORLD’S TOUGHEST CANCER

October 14, 2020

Article

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials

Taking on the World's Toughest Cancer

November 28, 2018

Article

Adaptive clinical trials are poised to deliver hope to patients with pancreatic cancer.

Your Treatment Plan: What You Need to Know

August 28, 2018

Article